Form D Explorer

Form D — GNT Pharmaceuticals, Inc.

0002057459-25-000001 · filed Mar 3, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$150,000
Reported amount sold
$0
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
GNT Pharmaceuticals, Inc.
CIK
2057459
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
3711 QUAIL HOLLOW COURT
LOUISVILLE, KY 40241
Phone
502-894-0295

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗